Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mimedx Group Inc (MDXG)
Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 937,999
  • Shares Outstanding, K 116,377
  • Annual Sales, $ 267,840 K
  • Annual Income, $ -30,200 K
  • 60-Month Beta 1.36
  • Price/Sales 3.01
  • Price/Cash Flow N/A
  • Price/Book 705.26
Trade MDXG with:

Options Overview Details

View History
  • Implied Volatility 65.17% ( -2.10%)
  • Historical Volatility 36.03%
  • IV Percentile 64%
  • IV Rank 26.30%
  • IV High 217.78% on 03/16/23
  • IV Low 10.73% on 03/30/23
  • Put/Call Vol Ratio 11.00
  • Today's Volume 60
  • Volume Avg (30-Day) 51
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 5,021
  • Open Int (30-Day) 4,884

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.08
  • Number of Estimates 3
  • High Estimate 0.08
  • Low Estimate 0.07
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.61 +7.49%
on 02/06/24
8.54 -4.19%
on 01/23/24
-0.29 (-3.42%)
since 01/22/24
3-Month
7.53 +8.63%
on 11/24/23
9.27 -11.76%
on 12/20/23
+0.61 (+8.06%)
since 11/22/23
52-Week
3.08 +165.58%
on 04/04/23
9.27 -11.76%
on 12/20/23
+3.64 (+80.18%)
since 02/22/23

Most Recent Stories

More News
3 A-Rated Medical Stocks to Watch and Buy

The medical industry is set for significant growth due to technological advances, increased demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality...

GSK : 42.16 (+1.51%)
MDXG : 8.18 (+1.49%)
NHC : 100.76 (+1.91%)
3 Medical Stocks Set to Soar in 2024

The healthcare industry in 2024 is shaped by personalized medicine and innovative technologies in pharmacy, diagnostic testing, and medical devices. Hence, fundamentally strong medical stocks CVS Health...

A : 132.02 (-2.45%)
CVS : 77.10 (-0.06%)
MDXG : 8.18 (+1.49%)
3 Solid Medical Stocks to Watch for Year-End Success and Beyond

The medical sector is poised for significant growth, driven by technological advances, robust demand for medicines due to an aging population, escalating healthcare costs, and the rising need for quality...

ELV : 512.17 (+0.55%)
MDXG : 8.18 (+1.49%)
NATR : 17.75 (-0.17%)
3 Medical Stocks Diagnosing Weekly Profit Potential

The healthcare industry is experiencing rapid transformation and is well-positioned to thrive due to the rising demand for high-quality healthcare and medical device innovation. Hence, fundamentally strong...

CAH : 107.15 (+1.49%)
MDXG : 8.18 (+1.49%)
NATR : 17.75 (-0.17%)
3 Medical Stocks Elevating Investors' Profit Potential

Within the rapidly evolving healthcare landscape, opportunities arise from operational improvements, making the sector poised for significant expansion. Hence, fundamentally strong medical stocks Cardinal...

CAH : 107.15 (+1.49%)
FSNUY : 6.9700 (-1.41%)
MDXG : 8.18 (+1.49%)
Henry Schein (HSIC) Q3 Earnings Analysis: A Medical Stock to Watch?

Henry Schein (HSIC) posted solid third-quarter 2023 sales growth and non-GAAP EPS growth despite continued lower sales of PPE products and COVID-19 test kits. In addition, the company’s long-term outlook...

FONR : 22.39 (-2.61%)
HSIC : 77.08 (+2.65%)
MDXG : 8.18 (+1.49%)
OCPNY : 18.0000 (-1.37%)
Assessing Alcon Inc.’s (ALC) Post-Earnings Prospects: Is It Time to Invest, Hold, or Let Go?

Is Swiss eye care leader Alcon Inc. (ALC) a buy, hold, or sell after its third-quarter earnings release yesterday? Let’s look at its financial metrics to gauge its prospects… Geneva, Switzerland-based...

ALC : 80.40 (+0.78%)
FONR : 22.39 (-2.61%)
MDXG : 8.18 (+1.49%)
VREX : 17.07 (+1.73%)
Are These 3 Medical Stocks a Safe Investment?

The future of the medical devices and equipment industry looks buoyant, given rising chronic conditions and the adoption of advanced technology. Given this backdrop, would it be prudent for investors to...

HAE : 74.90 (+2.22%)
MDXG : 8.18 (+1.49%)
TRUMY : 38.2300 (+1.27%)
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth

MiMedx Group, Inc. (NASDAQ: MDXG) is engaged as a biotechnology company that is focused as a placental biologics developer to

MDXG : 8.18 (+1.49%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 48.31 (+0.37%)
OCEL : 3.1900 (-8.60%)
BRTX : 1.3100 (-3.68%)
MDXG : 8.18 (+1.49%)
NNVC : 1.2700 (+2.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the...

See More

Key Turning Points

3rd Resistance Point 8.47
2nd Resistance Point 8.34
1st Resistance Point 8.26
Last Price 8.18
1st Support Level 8.05
2nd Support Level 7.92
3rd Support Level 7.84

See More

52-Week High 9.27
Last Price 8.18
Fibonacci 61.8% 6.91
Fibonacci 50% 6.18
Fibonacci 38.2% 5.44
52-Week Low 3.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar